Pressure Biosciences INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
10-Q: Pressure BioSciences Reports Q2 2024 Results, Cites Revenue Decline and Ongoing Financial Challenges
Pressure BioSciences, Inc. reports a decrease in revenue for Q2 2024 and the first half of the year, alongside ongoing concerns about its ability to continue as a going concern.
OTC.Pink
Pressure BioSciences, Inc. reports a decrease in revenue for Q1 2024 compared to Q1 2023, alongside the acquisition of Uncle Buds Health & Wellness.